Results

Total Results: 2,173 records

Showing results for "medications".
Users also searched for: medication reconciliation

381. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - The committee stated “the lack of obesity medications is a significant unmet medical need.” … had improved cardiovascular and metabolic risk factors and a decrease in the need for associated medications … Adjuvant medications are limited at present. … Additional medications which are safe could help to fill this gap.” 18 Experts generally agreed … reduction of HbA1c from 8.4% at baseline to 7.0% after 6 months, and reduced intake of antidiabetic medications

382. Ch 11-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
     January 03, 2012 - This is a sensible strategy in a general practice setting as these medications may be started long … Yet, as these medications may be used for decades, long-term users are of great interest. … including “nonusers,” “recent past users,” “distant past users,” and “users of other antihypertensive medications … Some medications may be less effective in some populations due to the different polymorphisms that … The example estimates the association between different statin medications with this biomarker.

383. high-cholesterol-medicines-update-protocol-130516 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
     December 31, 2013 - Nicotinic acid – niacin  Omega-3-acid ethyl esters  Prepackaged combinations of lipid-lowering medications …   Interventions Statin (in a lower dose) + other lipid- lowering medications … acid – niacin (IR, SR, or ER) • Omega-3-acid ethyl esters • Prepackaged combination lipid- lowering medications … , cholesterylester transfer protein inhibitors, and PCSK9 inhibitors • Prepackaged combination medications … List of FDA-approved lipid lowering medications or pharmaceutical agents Generic Name U.S.

384. High-Cholestorol-Medicines-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
     February 01, 2014 - Excluded studies of prepackaged medications that contained non–lipid-lowering medications. … there is insufficient evidence to address whether the LDL-c–lowering benefits achieved with these medications … Most trials we identified were of relatively short duration, despite the fact that these medications … are currently used in clinical practice as chronic long-term medications.

385. Topic-Brief2-Opioid-Withdrawal (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
     April 01, 2021 - and chronic pain management for individuals entitled to Medicare benefits.1 Issue Use of opioid medications … ); 3 studies Poor: 5 studies Detoxification Opioid dose reduction supported with symptomatic medications … U.S. prescribing trends of fentanyl, opioids, and other pain medications in outpatient and emergency … active or historic substance use disorders, including knowledge about complementary care, analgesic medications

386. Topic-Brief2-Opioid-Withdrawal (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
     April 01, 2021 - and chronic pain management for individuals entitled to Medicare benefits.1 Issue Use of opioid medications … ); 3 studies Poor: 5 studies Detoxification Opioid dose reduction supported with symptomatic medications … U.S. prescribing trends of fentanyl, opioids, and other pain medications in outpatient and emergency … active or historic substance use disorders, including knowledge about complementary care, analgesic medications

387. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non–ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/angina-heart-attack-treatments/research

388. Disposition of Comments Report for CER 203 ADHD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
     January 01, 2018 - The first-line recommendations for the use of FDA approved medications would mean that they could only … In fact, there other medications approved by the FDA during the time of scope of this review, including … These medications are differently formulated versions of already available therapies. … There is no evidence provided that medications should be the first line since the moderate levels are … However, Medicaid covers stimulant medications in all states.

389. CER 225: Evidence Summary Interventions for Substance Use Disorders in Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-evidence-summary%20225%20Substance%20Use%20Adolescents.pdf
     May 01, 2020 -  More research is needed to understand the role of medications in treatment of alcohol and cannabis

390. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
     May 01, 2012 - For preschoolers, psychostimulant medications are also generally safe and efficacious for improving … Because ADHD is a chronic disorder, many children, teens, and adults may stay on medications for years … Off-label use of medications in the preschool population is, however, common.20 Findings of the Draft … For preschoolers, psychostimulant medications are also generally safe and efficacious for improving … Also, the earlier comparative effectiveness review found a wide range of effect sizes for medications

391. Disposition of Comments Report for Recurrent Nephrolithiasis in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
     July 26, 2012 - Review of medications, dietary therapy, and adverse effects seem appropriate to me. Thank you. … to the future research section would be studies to evaluate the cost-effectiveness of using these medications … to the future research section would be studies to evaluate the cost-effectiveness of using these medications … The authors also ask about the comparative effectiveness of medications and dietary changes in stone … The authors also ask about the comparative effectiveness of medications and dietary changes in stone

392. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
     January 01, 2012 -   Bipolar Depression and Major Depressive Disorder  Key Facts: Despite widespread use, approved medications … Only a fraction of patients respond within a week of administration of many of the medications available … Food and Drug Administration (FDA) for treating PMD. 4 Effective medications are needed for this condition … typically first-line treatment involving concomitant use of antidepressant and antipsychotic 3 medications … this intervention. 43-49 The experts strongly agreed that the unmet need for rapidly effective medications

393. Crosscutting Hi Impact (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting_hi_impact.pdf
     January 01, 2012 - that patients wear as a patch on the torso to record heart rate, activity, ingestion of monitored medications … that patients wear as a patch on the torso to record heart rate, activity, ingestion of monitored medications … Patients would continue to take their medications in the same manner as before, as instructed by their … intended to provide physicians with more timely data on how patients are taking their prescribed medications … a more senior-friendly environment, assessment of needs, and education on current prescription medications

394. Noninvasive, Nonpharmacological Treatment for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharma-treatment-pain_research-protocol-amended.pdf
     September 20, 2017 - nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, opioids, muscle relaxants, antiseizure medications … therapies compared with pharmacological therapy (e.g., opioids, NSAIDS, acetaminophen, antiseizure medications … Non-opioid pharmacological therapy(nonsteroidal anti- inflammatory drugs, acetaminophen, antiseizure medications … nonsurgical treatments (e.g., injections, nerve block, spinal cord stimulators, parenterally- administered medications … All KQs subquestion b • Non-opioid pharmacological therapy (NSAIDS, acetaminophen, anti-seizure medications

395. Comparative Effectiveness Review Disposition of Comments Report: Anxiety in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
     August 31, 2017 - Peer Reviewer #1 Key Messages pg 8, line 16) (Would say that medications “may” result in adverse … for each individual types of therapy (psychoanalysis, etc) similar to what was done for individual medications … The studies compared CBT to CBT and medications. … We attempted to balance between CBT and medications as much as possible and remained consistent with … The review also restricts itself only to medications and traditional psychotherapy despite there being

396. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
     May 22, 2012 - studies have been published on the comparative safety and effectiveness of the different available medications … of sinus rhythm after cardioversion, the 2006 ACC/AHA/ESC Guidelines list different antiarrhythmic medications … the recommendations in the 2006 ACC/AHA/ESC Guidelines using published data on new antiarrhythmic medications … Guideline recommendations are depicted in Figure 1;19 however, which of these medications is best for … procedure now established as a clinically useful treatment option for symptomatic patients in whom medications

397. Disposition of Comments CER 194 Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
     March 19, 2018 - large number of inhaled corticosteroids, LAMA, LABA, and SABA available, including newly-approved medications … , clinicians (and patients), might find information on the types of medications and their mechanisms … Medication to be used as-needed for acute symptom relief “ and “controller therapy” is defined as “medications … Long-term controller medications include inhaled corticosteroids, inhaled long-acting bronchodilators … LAMA in various populations, it does not discuss the potential adverse effects associated with these medications

398. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
     July 18, 2011 - have been diagnosed correctly, and 49 percent use only over-the- counter rather than prescription medications … , which typically last 4 hours to 3 days if untreated and which frequently require bed rest, pain medications … this comparative effectiveness review (CER) is to assess the effectiveness of various parenteral medications … triamcynolon or triamsinoloni).tw. 110. or/93-109 111. or/10-109 Terms for parenteral administration of medications

399. App-D-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
     September 30, 2015 - Sex, income, geographic region, primary care provider availability, insurance coverage type, other medications … Analyzed: 4,622 Loss to followup: NA Race, sex, geographic region, economic status, comorbidities, other medications

400. S5 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
     October 01, 2007 - persistence, adherence, and continuity of pharma- ceutical use and to study benefits and adverse events of medications … in health care, and never more so than with the initiation of the Part D benefit for prescription medications